# FDA Inspection 848036 - Biomat USA, Inc - September 16, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f9fda89b-36ea-47e3-a550-99decd1133ae/
Source feed: FDA_Inspections

> FDA Inspection 848036 for Biomat USA, Inc on September 16, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 848036
- Company Name: Biomat USA, Inc
- Inspection Date: 2013-09-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1118233 - 2020-01-24](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/28eadcdb-5b30-43a9-ba74-f80629374908/)
- [FDA Inspection 1007840 - 2017-04-18](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/a6ca64c1-ef6c-4c76-a9db-f8e906d027b3/)
- [FDA Inspection 929570 - 2015-06-10](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/f0013622-aee8-459d-94f7-227256e99cde/)
- [FDA Inspection 747451 - 2011-09-21](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/49757e9d-6fc6-4a94-9f8c-fa3e2864e915/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/671cad35-24d3-4270-8d71-e22c4aec248e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d